Animas Corporation

Animas Corporation was an American company that specialized in making insulin pumps. The company was founded by Katherine Crothall in 1996, had its initial public offering in May 2004 under the ticker symbol 'PUMP', and was ultimately acquired by Johnson & Johnson on February 18, 2006. The business was headquartered in West Chester, Pennsylvania and forms part of the Johnson & Johnson Diabetes franchise along with Lifescan and several other companies producing medical products for the treatment and management of diabetes.

Animas Corporation
Founded1996
FounderKatherine Crothall
Headquarters
West Chester, Pennsylvania
ProductsInsulin pumps

On October 5, 2017 Johnson & Johnson's Animas Corporation announced that they are closing down their operations in the insulin pump market and had sold their customer database to (“partnered with”) Medtronic.[1]

Animas 2020

The Animas 2020 is an insulin pump that carries 200 units of insulin and can be connected to an infusion set following the Luer standard. Its predecessor was the Animas IR1250.

In April 2013, the Food and Drug Administration issued a Class I Recall for the Animas 2020. The recall specifies an issue with the pump initiating a false alarm or warning sound, which may prompt pump users to inadvertently administer more insulin and can result in a serious health risk.[2]

Since December 31, 2015, the unit no longer functions. After this date, the device generates a "Call Service Alarm". This end of use date was not included in the product labeling.[3]

Animas Ping

The Animas Ping is an insulin pump which communicates wirelessly with a meter/display device.[4]

Animas Vibe

In November 2014, the FDA approved the Animas Vibe for managing insulin-required diabetes in adults.[5][6][7]

References
  1. "Animas Corporation to Close Operations and Exit Insulin Pump Market". Content Lab - U.S.
  2. "Animas Corporation 2020 Insulin Infusion Pump: Class I Recall - False Alarm or Warning Sound". www.fda.gov. Archived from the original on 9 April 2013. Retrieved 17 January 2022.
  3. "Important Information about Animas® 2020, IR1250 and IR1200 Insulin Pumps" (PDF). Archived from the original (PDF) on 7 July 2017. Retrieved 6 August 2023.
  4. "OneTouch Ping". Diabetesnet.com. 22 November 2010.
  5. Batts, Andy (4 December 2014). "Update: FDA Clears Johnson & Johnson's Insulin Pump, An Artificial Pancreas Quickened". Seeking Alpha.
  6. "Animas Vibe Insulin Pump And Continuous Glucose Monitoring System Receives FDA Approval". www.meddeviceonline.com.
  7. "Advances in predictive hypoglycemia-minimizing technology from Animas-JDRF collaboration". EurekAlert!.

Sources

Canadian Insulin Pump Users:

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.